Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Classic Follicular Lymphoma · Follicular Lymphoma With Unusual Cytological Features

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

    Contact: Study coordinator (Site Public Contact) · gingerreeves@uabmc.edu
    Contact: Principal Investigator (Aditi Saha)
  • Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Jose C. Villasboas)
  • Banner University Medical Center - Tucson, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Krishna Rekha Moturi)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Krishna Rekha Moturi)
  • Highlands Oncology Group - Fayetteville, Fayetteville, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8100
    Contact: Principal Investigator (Joseph T. Beck)
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 501-686-8274
    Contact: Principal Investigator (Mamatha Gaddam)
  • Highlands Oncology Group - Rogers, Rogers, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8130
    Contact: Principal Investigator (Joseph T. Beck)
  • Highlands Oncology Group, Springdale, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8130
    Contact: Principal Investigator (Joseph T. Beck)
  • Tower Cancer Research Foundation, Beverly Hills, California, United States

    Contact: Study coordinator (Site Public Contact) · towercancerresearch@toweroncology.com
    Contact: Principal Investigator (Akil A. Merchant)
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Tycel J. Phillips)
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Elizabeth A. Brem)
  • City of Hope at Irvine Lennar, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Tycel J. Phillips)
  • City of Hope Antelope Valley, Lancaster, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Tycel J. Phillips)
  • City of Hope at Long Beach Elm, Long Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Tycel J. Phillips)
  • Tibor Rubin VA Medical Center, Long Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 562-826-8000
    Contact: Principal Investigator (Helen Ma)
  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · Cancer.trial.info@cshs.org · 310-423-2133
    Contact: Principal Investigator (Akil A. Merchant)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Elizabeth A. Brem)
  • City of Hope South Pasadena, South Pasadena, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Tycel J. Phillips)
  • Torrance Memorial Physician Network - Cancer Care, Torrance, California, United States

    Contact: Study coordinator (Site Public Contact) · courtney.steeneken@tmphysicians.com · 310-750-3300
    Contact: Principal Investigator (Akil A. Merchant)
  • City of Hope Upland, Upland, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Tycel J. Phillips)
  • UCHealth University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Manali K. Kamdar)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Manali K. Kamdar)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Manali K. Kamdar)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Manali K. Kamdar)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Manali K. Kamdar)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-444-2223
    Contact: Principal Investigator (Joseph L. Roswarski)
  • Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · jquiver1@jhmi.edu · 202-243-2373
    Contact: Principal Investigator (Nina D. Wagner-Johnston)
  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 954-461-2180
    Contact: Principal Investigator (Michele Stanchina)
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Michele Stanchina)
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Michele Stanchina)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Michele Stanchina)
  • UM Sylvester Comprehensive Cancer Center at Doral, Doral, Florida, United States

    Contact: Study coordinator (Site Public Contact) · kginnity@med.miami.edu
    Contact: Principal Investigator (Michele Stanchina)
  • UM Sylvester Comprehensive Cancer Center at Hollywood, Hollywood, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Michele Stanchina)
  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Jose C. Villasboas)
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Michele Stanchina)
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Michele Stanchina)
  • Mount Sinai Medical Center, Miami Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · Yvonne.Enriquez@msmc.com · 305-674-2625
    Contact: Principal Investigator (Jacqueline C. Barrientos)
  • University of Miami Sylvester Comprehensive Cancer Center at Sole Mia, North Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · kginnity@med.miami.edu
    Contact: Principal Investigator (Michele Stanchina)
  • Memorial Hospital West, Pembroke Pines, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 954-265-4325
    Contact: Principal Investigator (Carlos Silva Rondon)
  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Michele Stanchina)
  • Moffitt Cancer Center at SouthShore, Ruskin, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Sameh R. Gaballa)
  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Sameh R. Gaballa)
  • Moffitt Cancer Center at Wesley Chapel, Wesley Chapel, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Sameh R. Gaballa)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Kristie A. Blum)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Kristie A. Blum)
  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-851-7115
    Contact: Principal Investigator (Kristie A. Blum)
  • Augusta University Medical Center, Augusta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · ga_cares@augusta.edu · 706-721-2388
    Contact: Principal Investigator (Locke J. Bryan)
  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

  • Illinois CancerCare-Canton, Canton, Illinois, United States

  • Illinois CancerCare-Carthage, Carthage, Illinois, United States

  • Swedish Covenant Hospital, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-878-8200
    Contact: Principal Investigator (Robert M. Eisner)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Peter Riedell)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Dixon, Dixon, Illinois, United States

  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Elmhurst Memorial Hospital, Elmhurst, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Jrohde@emhc.org · 630-758-5460
    Contact: Principal Investigator (Joseph Heng)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

  • NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Robert M. Eisner)
  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Robert M. Eisner)
  • NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Robert M. Eisner)
  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Edward Hospital/Cancer Center, Naperville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 630-646-6075
    Contact: Principal Investigator (Joseph Heng)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Peter Riedell)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Peter Riedell)
  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

  • Illinois CancerCare-Peru, Peru, Illinois, United States

  • Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancerresearch@edward.org · 630-646-6075
    Contact: Principal Investigator (Joseph Heng)
  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

  • Memorial Hospital East, Shiloh, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · dschwab@wustl.edu · 314-747-9912
    Contact: Principal Investigator (Brad S. Kahl)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

  • Northwest Cancer Center - Crown Point, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@powershealth.org · 219-836-6879
    Contact: Principal Investigator (Suparna Mantha)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Peter Riedell)
  • Northwest Oncology LLC, Dyer, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-924-8178
    Contact: Principal Investigator (Suparna Mantha)
  • Northwest Cancer Center - Hobart, Hobart, Indiana, United States

  • Saint Mary Medical Center, Hobart, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Suparna Mantha)
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Khushali Jhaveri)
  • Saint Catherine Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Suparna Mantha)
  • The Community Hospital, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-836-3349
    Contact: Principal Investigator (Suparna Mantha)
  • Women's Diagnostic Center - Munster, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · mnicholson@comhs.org · 219-934-8869
    Contact: Principal Investigator (Suparna Mantha)
  • Northwest Cancer Center - Valparaiso, Valparaiso, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Suparna Mantha)
  • Mary Greeley Medical Center, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · katherine-daprile@uiowa.edu · 563-355-7733
    Contact: Principal Investigator (Eric Mou)
  • McFarland Clinic - Boone, Boone, Iowa, United States

  • Mercy Hospital, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-365-4673
    Contact: Principal Investigator (Deborah W. Wilbur)
  • Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-363-2690
    Contact: Principal Investigator (Deborah W. Wilbur)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (Eric Mou)
  • McFarland Clinic - Jefferson, Jefferson, Iowa, United States

  • McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • HaysMed, Hays, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-623-5774
    Contact: Principal Investigator (Marc S. Hoffmann)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Marc S. Hoffmann)
  • Lawrence Memorial Hospital, Lawrence, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.Norris@LMH.ORG · 785-505-2800
    Contact: Principal Investigator (Marc S. Hoffmann)
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth, Kansas, United States

  • The University of Kansas Cancer Center - Olathe, Olathe, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · OlatheCCResearch@kumc.edu · 913-588-1569
    Contact: Principal Investigator (Marc S. Hoffmann)
  • University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Marc S. Hoffmann)
  • Salina Regional Health Center, Salina, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · mleepers@srhc.com · 785-452-7038
    Contact: Principal Investigator (Marc S. Hoffmann)
  • University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-295-8000
    Contact: Principal Investigator (Marc S. Hoffmann)
  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Marc S. Hoffmann)
  • LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · research@ololrmc.com · 225-765-7659
    Contact: Principal Investigator (Nakhle S. Saba)
  • Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · research@ololrmc.com · 225-765-7659
    Contact: Principal Investigator (Nakhle S. Saba)
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · jhcccro@jhmi.edu · 410-955-8804
    Contact: Principal Investigator (Nina D. Wagner-Johnston)
  • Walter Reed National Military Medical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 301-319-2100
    Contact: Principal Investigator (Christin Destefano)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Yasmin H. Karimi)
  • Bronson Battle Creek, Battle Creek, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Jawad Sheqwara)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Jawad Sheqwara)
  • Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Jawad Sheqwara)
  • Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 800-527-6266
    Contact: Principal Investigator (Dipenkumar Modi)
  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Jawad Sheqwara)
  • Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Dipenkumar Modi)
  • Cancer Hematology Centers - Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Genesee Hematology Oncology PC, Flint, Michigan, United States

  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Allegiance Health, Jackson, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Jawad Sheqwara)
  • Bronson Methodist Hospital, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • West Michigan Cancer Center, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Muskegon Hospital, Muskegon, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · connie.szczepanek@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Henry Ford Health Providence Novi Hospital, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kfife3@hfhs.org · 248-849-5332
    Contact: Principal Investigator (Jawad Sheqwara)
  • Henry Ford Medical Center-Columbus, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Jawad Sheqwara)
  • Hope Cancer Center, Pontiac, Michigan, United States

  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Corewell Health Reed City Hospital, Reed City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Henry Ford Health Providence Southfield Hospital, Southfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kfife3@hfhs.org · 248-849-5332
    Contact: Principal Investigator (Jawad Sheqwara)
  • Munson Medical Center, Traverse City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Jawad Sheqwara)
  • Henry Ford Wyandotte Hospital, Wyandotte, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · nhay@hfhs.org
    Contact: Principal Investigator (Jawad Sheqwara)
  • University of Michigan Health - West, Wyoming, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Jose C. Villasboas)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Saint Francis Regional Medical Center, Shakopee, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Salil Goorha)
  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Saint Luke's Hospital, Chesterfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-205-6936
    Contact: Principal Investigator (Mark J. Fesler)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brad S. Kahl)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brad S. Kahl)
  • Parkland Health Center - Farmington, Farmington, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • University Health Truman Medical Center, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 816-404-4375
    Contact: Principal Investigator (Marc S. Hoffmann)
  • University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 913-588-3671
    Contact: Principal Investigator (Marc S. Hoffmann)
  • Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 800-525-1483
    Contact: Principal Investigator (Suman Kambhampati)
  • University of Kansas Cancer Center - North, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Marc S. Hoffmann)
  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Marc S. Hoffmann)
  • Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brad S. Kahl)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brad S. Kahl)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brad S. Kahl)
  • Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Site Public Contact) · cancer.research.nurse@dartmouth.edu · 800-639-6918
    Contact: Principal Investigator (Charles Gaulin)
  • Saint Barnabas Medical Center, Livingston, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · joanne.loeb@rwjbh.org · 973-322-2934
    Contact: Principal Investigator (Joanna M. Rhodes)
  • Monmouth Medical Center, Long Branch, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · mary.danish@rwjbh.org · 732-923-6564
    Contact: Principal Investigator (Joanna M. Rhodes)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Joanna M. Rhodes)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Carla Casulo)
  • Wilmot Cancer Institute at Webster, Webster, New York, United States

    Contact: Study coordinator (Site Public Contact) · WCICTOresearch@urmc.rochester.edu
    Contact: Principal Investigator (Carla Casulo)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Christopher E. Jensen)
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Nilanjan Ghosh)
  • Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kashah@novanthealth.org · 980-201-6360
    Contact: Principal Investigator (Alan P. Skarbnik)
  • Atrium Health Pineville/LCI-Pineville, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Nilanjan Ghosh)
  • Levine Cancer Institute-SouthPark, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Nilanjan Ghosh)
  • Atrium Health University City/LCI-University, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Nilanjan Ghosh)
  • Wake Forest University at Clemmons, Clemmons, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-716-9259
    Contact: Principal Investigator (Rakhee Vaidya)
  • Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Nilanjan Ghosh)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Andrea Sitlinger)
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 910-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Atrium Health Union/LCI-Union, Monroe, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Nilanjan Ghosh)
  • Novant Health Cancer Institute - Mooresville, Mooresville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kashah@novanthealth.org · 980-201-6360
    Contact: Principal Investigator (Alan P. Skarbnik)
  • Novant Health Forsyth Medical Center, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · pjordan@novanthealth.org · 336-718-8335
    Contact: Principal Investigator (James P. Dugan)
  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Rakhee Vaidya)
  • Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Yazeed Sawalha)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Taha Al-Juhaishi)
  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Kaiser Permanente Northwest, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · information@kpchr.org · 503-335-2400
    Contact: Principal Investigator (Abdul Hai Mansoor)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · trials@ohsu.edu · 503-494-1080
    Contact: Principal Investigator (Tanaya Shree)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Seyfettin O. Alpdogan)
  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 215-728-4790
    Contact: Principal Investigator (Marcus Messmer)
  • Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Seyfettin O. Alpdogan)
  • Rhode Island Hospital, Providence, Rhode Island, United States

    Contact: Study coordinator (Site Public Contact) · 401-444-1488
    Contact: Principal Investigator (Adam J. Olszewski)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Brian T. Hess)
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Salil Goorha)
  • UT MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 866-632-6789
    Contact: Principal Investigator (Paolo Strati)
  • University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Site Public Contact) · phoresearchoffice@uthscsa.edu · 210-450-3800
    Contact: Principal Investigator (Leyla Bojanini Molina)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Allison Bock)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303
    Contact: Principal Investigator (Nathan L. Roberts)
  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (Bharadhwaj Kolipakkam)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Bharadhwaj Kolipakkam)
  • West Virginia University Charleston Division, Charleston, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 304-388-9944
    Contact: Principal Investigator (Ahmed A. Khalid)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3604
    Contact: Principal Investigator (Yazhini Vallatharasu)
  • ThedaCare Regional Medical Center - Appleton, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3605
    Contact: Principal Investigator (Yazhini Vallatharasu)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Isaac K. Yeboah)
  • Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · cancerctr@gundersenhealth.org · 608-775-2385
    Contact: Principal Investigator (David E. Marinier)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Isaac K. Yeboah)
  • Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-257-5100
    Contact: Principal Investigator (Mehdi Hamadani)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Mehdi Hamadani)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Froedtert and MCW Moorland Reserve Health Center, New Berlin, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Mehdi Hamadani)
  • Drexel Town Square Health Center, Oak Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Mehdi Hamadani)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Isaac K. Yeboah)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Mehdi Hamadani)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Isaac K. Yeboah)
מובילי המחקר
  • Nilanjan Ghosh

    Principal Investigator

    SWOG Cancer Research Network